Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May;99(5):486-495.
doi: 10.1111/imcb.12444. Epub 2021 Feb 21.

Harnessing CD8+ T-cell exhaustion to treat type 1 diabetes

Chun-Ting J Kwong  1   2 , Claudia Selck  1   2 , Krisna Tahija  1   2 , Lachlan J McAnaney  1   2 , Dan V Le  1   2 , Thomas Wh Kay  1   2 , Helen E Thomas  1   2 , Balasubramanian Krishnamurthy  1   2
Affiliations
Review

Harnessing CD8+ T-cell exhaustion to treat type 1 diabetes

Chun-Ting J Kwong et al. Immunol Cell Biol. 2021 May.

Abstract

Although immune interventions have shown great promise in type 1 diabetes mellitus (T1D) clinical trials, none are yet in routine clinical use or able to achieve insulin independence in patients. In addition to this, the principles of T1D treatment remain essentially unchanged since the isolation of insulin, almost a century ago. T1D is characterized by insulin deficiency as a result of destruction of insulin-producing beta cells mediated by autoreactive T cells. Therapies that target beta-cell antigen-specific T cells are needed to prevent T1D. CD8+ T-cell exhaustion is an emerging area of research in chronic infection, cancer immunotherapy, and more recently, autoimmunity. Recent data suggest that exhausted T-cell populations are associated with improved markers of T1D. T-cell exhaustion is both characterized and mediated by inhibitory receptors. This review aims to identify which inhibitory receptors may prove useful to induce T-cell exhaustion to treat T1D and identify limitations and gaps in the current literature.

Keywords: CD8+ T cells; PD-1; T-cell exhaustion; Type 1 diabetes.

PubMed Disclaimer

References

    1. Pugliese A. Autoreactive T cells in type 1 diabetes. J Clin Invest 2017; 127: 2881-2891.
    1. Graham KL, Sutherland RM, Mannering SI, et al. Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease. Rev Diabet Stud 2012; 9: 148-168.
    1. Yu W, Jiang N, Ebert PJ, et al. Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8+ T Lymphocytes. Immunity 2015; 42: 929-941.
    1. Culina S, Lalanne AI, Afonso G, et al. Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors. Sci Immunol 2018; 3: eaao4013.
    1. Mallone R, Eizirik DL. Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes? Diabetologia 2020; 63: 1999-2006.

Publication types